MedTrace Logo

Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice

NCT07501780 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 297

Last updated 2026-03-30

No results posted yet for this study

Summary

Basal cell carcinoma (BCC) is the most common skin cancer in the Netherlands, with incidence rates continuing to rise. The current diagnostic standard combines clinical evaluation and dermoscopy, while biopsy followed by histopathological examination remains the gold standard when uncertainty about the diagnosis persists. However, biopsy is invasive, time-consuming, and costly. Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive imaging technique that has emerged as a promising alternative to biopsy for BCC suspected lesions.

This retrospective study aims to evaluate the real-world clinical performance of LC-OCT in routine dermatological practice, where it has been integrated into the diagnostic work-up for BCC-suspect lesions.

Conditions

  • Basal Cell Carcinoma of Skin
  • Optical Coherence Tomography (OCT)
  • Neoplasms
  • Neoplasms, Basal Cell
  • Carcinoma, Basal Cell (BCC)
  • Real-world Study
  • Implementation

Sponsors & Collaborators

  • Mohs Klinieken

    collaborator UNKNOWN

  • Maastricht University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-15
Primary Completion
2027-03-15
Completion
2027-12-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07501780 on ClinicalTrials.gov